Skip to main content

Amyloid-β42/40 ratio drives tau pathology in 3D human neural cell culture models of Alzheimer's disease.

Citation
Kwak, S. S., et al. “Amyloid-Β42/40 Ratio Drives Tau Pathology In 3D Human Neural Cell Culture Models Of Alzheimer's Disease.”. Nature Communications, p. 1377.
Center Boston Area
Author Sang Su Kwak, Kevin J Washicosky, Emma Brand, Djuna von Maydell, Jenna Aronson, Susan Kim, Diane E Capen, Murat Cetinbas, Ruslan Sadreyev, Shen Ning, Enjana Bylykbashi, Weiming Xia, Steven L Wagner, Se Hoon Choi, Rudolph E Tanzi, Doo Yeon Kim
Abstract

The relationship between amyloid-β (Aβ) species and tau pathology in Alzheimer's disease (AD) is not fully understood. Here, we provide direct evidence that Aβ42/40 ratio, not total Aβ level, plays a critical role in inducing neurofibrillary tangles (NTFs) in human neurons. Using 3D-differentiated clonal human neural progenitor cells (hNPCs) expressing varying levels of amyloid β precursor protein (APP) and presenilin 1 (PS1) with AD mutations, we show that pathogenic tau accumulation and aggregation are tightly correlated with Aβ42/40 ratio. Roles of Aβ42/40 ratio on tau pathology are also confirmed with APP transmembrane domain (TMD) mutant hNPCs, which display differential Aβ42/40 ratios without mutant PS1. Moreover, naïve hNPCs co-cultured with APP TMD I45F (high Aβ42/40) cells, not with I47F cells (low Aβ42/40), develop robust tau pathology in a 3D non-cell autonomous cell culture system. These results emphasize the importance of reducing the Aβ42/40 ratio in AD therapy.

Year of Publication
2020
Journal
Nature communications
Volume
11
Issue
1
Number of Pages
1377
Date Published
12/2020
ISSN Number
2041-1723
DOI
10.1038/s41467-020-15120-3
Alternate Journal
Nat Commun
PMID
32170138
PMCID
PMC7070004
Download citation